Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mas Chaponda

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|April 13, 2011
Hypersensitivity reactions to HIV therapyMas Chaponda, Munir Pirmohamed
Cureus|November 7, 2022
Acute Epstein-Barr Virus Infection Complicated by Rhabdomyolysis: A Case Report and Literature ReviewMohannad Faisal, Amr Ashour, Israa Alshahwani, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 21, 2023
Investigating zero transmission of HIV in the MSM population: a UK modelling case studyKatherine Massey, Vittoria Vardanega, Mas Chaponda, et al.
International Journal of STD & AIDS|February 3, 2018
Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UKMas Chaponda, Natalie Aldhouse, Michel Kroes, et al.
Cureus|November 21, 2022
Elizabethkingia meningoseptica Infection in COVID-19 PatientsMas Chaponda, Adila Shaukat, Mohammad Wajeh Dulli, et al.
Cureus|April 21, 2025
A Systematic Literature Review on Pre-exposure Prophylaxis as a Strategy for HIV Risk Reduction in the Middle EastMas Chaponda, Ahmed A AlHammadi, Ali Alsaeed, et al.
Qatar Medical Journal|January 2, 2026
Clinical outcome and cost of intravenous, OPAT, and oral treatment of Gram-negative bacteremiaMas Chaponda, Farah Maher, Joanne Daghfal, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravirHelen E Reynolds, Ales Chrdle, Deirdre Egan, et al.
The Lancet. Global Health|September 16, 2017
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysisAlexander J Stockdale, Mas Chaponda, Apostolos Beloukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSamir Aoudjane, Mas Chaponda, Antonio Adrián González Del Castillo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|April 13, 2011
Hypersensitivity reactions to HIV therapyMas Chaponda, Munir Pirmohamed
Cureus|November 7, 2022
Acute Epstein-Barr Virus Infection Complicated by Rhabdomyolysis: A Case Report and Literature ReviewMohannad Faisal, Amr Ashour, Israa Alshahwani, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 21, 2023
Investigating zero transmission of HIV in the MSM population: a UK modelling case studyKatherine Massey, Vittoria Vardanega, Mas Chaponda, et al.
International Journal of STD & AIDS|February 3, 2018
Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UKMas Chaponda, Natalie Aldhouse, Michel Kroes, et al.
Cureus|November 21, 2022
Elizabethkingia meningoseptica Infection in COVID-19 PatientsMas Chaponda, Adila Shaukat, Mohammad Wajeh Dulli, et al.
Cureus|April 21, 2025
A Systematic Literature Review on Pre-exposure Prophylaxis as a Strategy for HIV Risk Reduction in the Middle EastMas Chaponda, Ahmed A AlHammadi, Ali Alsaeed, et al.
Qatar Medical Journal|January 2, 2026
Clinical outcome and cost of intravenous, OPAT, and oral treatment of Gram-negative bacteremiaMas Chaponda, Farah Maher, Joanne Daghfal, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravirHelen E Reynolds, Ales Chrdle, Deirdre Egan, et al.
The Lancet. Global Health|September 16, 2017
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysisAlexander J Stockdale, Mas Chaponda, Apostolos Beloukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSamir Aoudjane, Mas Chaponda, Antonio Adrián González Del Castillo, et al.
Pageof 2